More than 100 researchers, scientists and public health professionals
want fentanyl-related substances to no longer be Schedule I drugs —
saying a different classification has the potential to unlock research
on those drugs to treat opioid addiction or other mental health
conditions. Daniel Payne and Ben Leonard unpack a Tuesday letter sent to
the White House. Plus, Jason Gibbons, a postdoctoral fellow at Johns
Hopkins University, explains a new study on using buprenorphine in
Medicare patients.
view more